These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15638895)

  • 1. The economic consequences of prostate and bladder cancer in the UK.
    Sangar VK; Ragavan N; Matanhelia SS; Watson MW; Blades RA
    BJU Int; 2005 Jan; 95(1):59-63. PubMed ID: 15638895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
    Guest JF; Cookson RF
    Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
    Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
    BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
    Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.
    Cockerell OC; Hart YM; Sander JW; Shorvon SD
    Epilepsy Res; 1994 Jul; 18(3):249-60. PubMed ID: 7805646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual cost of bipolar disorder to UK society.
    Das Gupta R; Guest JF
    Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired pneumonia: the annual cost to the National Health Service in the UK.
    Guest JF; Morris A
    Eur Respir J; 1997 Jul; 10(7):1530-4. PubMed ID: 9230242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
    Krahn MD; Coombs A; Levy IG
    CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG; Toumi I; Hemels ME
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.
    Gordon LG; Tuffaha HW; James R; Keller AT; Lowe A; Scuffham PA; Gardiner RA
    Urol Oncol; 2018 Mar; 36(3):91.e7-91.e15. PubMed ID: 29169847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The annual cost of blood transfusions in the UK.
    Varney SJ; Guest JF
    Transfus Med; 2003 Aug; 13(4):205-18. PubMed ID: 12880391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of prostate cancer.
    Roehrborn CG; Black LK
    BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study).
    Grange F; Mohr P; Harries M; Ehness R; Benjamin L; Siakpere O; Barth J; Stapelkamp C; Pfersch S; McLeod LD; Kaye JA; Wolowacz S; Kontoudis I
    Melanoma Res; 2017 Dec; 27(6):607-618. PubMed ID: 28800027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual cost of erectile dysfunction to UK Society.
    Plumb JM; Guest JF
    Pharmacoeconomics; 1999 Dec; 16(6):699-709. PubMed ID: 10724796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A; Scuffham P; Shearer A; Oglesby A
    J Diabetes Complications; 2004; 18(1):18-26. PubMed ID: 15019595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of dialysis for elderly people in the UK.
    Grun RP; Constantinovici N; Normand C; Lamping DL;
    Nephrol Dial Transplant; 2003 Oct; 18(10):2122-7. PubMed ID: 13679490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
    Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
    Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom.
    Kellen E; Zeegers MP; Dirx M; Houterman S; Droste J; Lawrence G; Truyers C; Bruckers L; Molenberghs G; Joniau S; Buntinx F
    Eur J Cancer; 2007 Jul; 43(11):1694-700. PubMed ID: 17531466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.